SCHEMBL31201166

SCHEMBL31201166

CCC(CC)Nc1cc(Nc2ccccn2)c2nnc(C(C)C)n2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 1/20 0.41
▸ GABRG2 P18507 1/20 0.41
▸ GABRB3 P28472 1/20 0.41
▸ GABRA5 P31644 1/20 0.41
▸ GABRA3 P34903 1/20 0.41
▸ GABRA2 P47869 1/20 0.41
▸ MAPK10 P53779 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ DYRK1A Q13627 8/20 0.38
▸ CCNA2 P20248 7/20 0.38
▸ CDK2 P24941 7/20 0.38
▸ CDK5 Q00535 7/20 0.38
▸ CDK5R1 Q15078 7/20 0.38
▸ CCNA1 P78396 5/20 0.38
▸ SYK P43405 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ TYK2 P29597 2/20 0.33
▸ GRM5 P41594 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31201095 0.94 DYRK1A (0.46) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201383 0.88 GABRA1 (0.36) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201386 0.87 GABRA1 (0.33) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201240 0.86 CCNA2 (0.39) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201150 0.86 TYK2 (0.36) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201130 0.85 CCNA2 (0.33) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201257 0.85 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201350 0.84 GABRA1 (0.33) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201379 0.84 CRHR1 (0.38) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201421 0.83 CDK2 (0.34) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP claimed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO claimed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP claimed
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP disclosed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO disclosed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP disclosed
Send feedback